Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB Published: 22.04.2023 Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million Published: 29.03.2023 Navamedic ASA: Q4 2022 financial results Published: 16.02.2023 Navamedic ASA: Invitation to 2022 4th quarter presentation Published: 13.02.2023 Navamedic ASA: Q3 2022 financial results Published: 01.11.2022 Navamedic ASA: Invitation to 2022 third quarter presentation Published: 25.10.2022 FirstPrevious23456NextLast
Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB Published: 22.04.2023
Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million Published: 29.03.2023